Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
Ipecac syrup is obtained from the root and rhizome of the the ipecac plant, native to Central America and northern South America. Contains emetine and cephalin, two isoquinoline alkaloids. It is a very effective emetic used in acute poisoning. It also has expectorant properties. There are no indications from Commission E of the German Ministry of Health (Blumenthal 1998). Oral administration. (Martindale, Drugbank, WHO 2007)
Since the last update we have not found published data on its excretion in breastmilk.
Its rapid elimination allows safe breastfeeding two to three hours after administration, provided that the mother is well.
The marketing of the ipecac plant has been prohibited or restricted due to its toxicity in several countries. (MSC 2004)
Recommendations for Drugs in the Eleventh WHO Model List of Essential Drugs: compatible with Breastfeeding. (WHO 2002)